{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-024228","form_type":"8-K","ticker":"JAGX","cik":"0001585608","company_name":"Jaguar Health, Inc.","filed_at":"2025-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.086778+00:00","generated_at":"2026-05-26T08:51:21.036448+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Jaguar Health extends maturity of $6.22M secured note to Jan 20, 2026","bullets":["Note originally issued Jan 19, 2021; maturity extended from undated to Jan 20, 2026.","Principal amount remains $6,220,812.50; no other terms changed publicly.","Amendment dated Feb 13, 2025 between Jaguar Health, Napo Pharma, and Streeterville Capital.","Extension provides additional time to repay; no default or acceleration mentioned."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-024228","json":"https://secwatch.observer/filing/0000950170-25-024228.json","markdown":"https://secwatch.observer/filing/0000950170-25-024228.md","text":"https://secwatch.observer/filing/0000950170-25-024228.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000095017025024228/0000950170-25-024228-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000095017025024228/jagx-20250219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T08:51:21.036448+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}